Status:
COMPLETED
Localization of Nonpalpable Breast Lesions
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Breast Cancer
Carcinoma in Situ
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Each year the Danish mammography-screening programme identifies a large number of patients with small non-palpable breast cancers or precancerous lesions. The majority of these patients are suitable f...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with nonpalpable breast lesions, carcinoma in situ or invasive carcinoma, where preoperative lesion localization is necessary.
- All age groups, minimum 18 years
- Exclusion criteria:
- Patients with benign nonpalpable breast lesions.
- Patients who are unable to comprehend the information.
- Patients who are pregnant, breastfeeding or have children \< 3 years.
- Patients who have lesions, which requires more than two wires or seeds for localization.
Exclusion
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
410 Patients enrolled
Trial Details
Trial ID
NCT01901991
Start Date
January 1 2014
End Date
February 1 2016
Last Update
August 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet (Copenhagen University Hospital)
Copenhagen, Østerbro, Denmark, 2100